Company Description
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand.
Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems.
It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services.
The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016.
DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
| Country | United States |
| Founded | 2011 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 294 |
| CEO | Erez Raphael |
Contact Details
Address: 122 W 57th St,, #33B New York, New York 10019 United States | |
| Website | dariohealth.com |
Stock Details
| Ticker Symbol | DRIO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001533998 |
| CUSIP Number | 23725P209 |
| ISIN Number | US23725P2092 |
| Employer ID | 45-2973162 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Erez Raphael | Chief Executive Officer and Director |
| Zvi Ben David CPA | Chief Financial Officer, Treasurer and Secretary |
| Dov Oppenheim | Co-Founder and Production Chief |
| Josh Fischer | Senior Vice President of Operations and Compliance |
| Tomer Ben-Kiki | Chief Technology Officer |
| Kat Parrella | Investor Relations Manager |
| Mona Dean | Chief Compliance Officer |
| Claudia Levi | Content and Communications Manager |
| Limor Drezner | Chief People Officer |
| Jean Christophe Muyl | Head of Commercialization North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SCHEDULE 13G/A | Filing |
| Nov 7, 2024 | 10-Q | Quarterly Report |
| Oct 29, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Oct 24, 2024 | DEF 14A | Other definitive proxy statements |
| Sep 20, 2024 | 8-K | Current Report |
| Sep 13, 2024 | 8-K | Current Report |
| Aug 8, 2024 | 10-Q | Quarterly Report |
| Jul 5, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 28, 2024 | 8-K | Current Report |
| Jun 25, 2024 | 8-K | Current Report |